TOUS - ETF AI Analysis

Top Page

T. Rowe Price International Equity ETF (TOUS)

Rating:65Neutral

Price Target:―

TOUS, the T. Rowe Price International Equity ETF, earns a solid overall rating thanks to high-quality leaders like AstraZeneca and ASML, which bring strong financial performance, growth prospects, and strategic initiatives in healthcare and advanced technology. Additional support comes from well-positioned names such as UniCredit, Roche, and Siemens, which combine solid profitability with generally reasonable valuations. The main risk is that some holdings, like Renesas Electronics and Deutsche Telekom, face weaker momentum or financial challenges, and the fund is notably concentrated in non-U.S. markets, which can add regional and currency risk.

Positive Factors

Broad International Diversification

The fund spreads its investments across many countries in Europe, Asia, and North America, which helps reduce the impact of problems in any single market.

Balanced Sector Mix

Holdings are spread across financials, industrials, technology, health care, and several other sectors, limiting reliance on any one part of the economy.

Supportive Asset Base and Recent Performance

The ETF manages over a billion dollars and has shown steady gains over the past month, three months, and year-to-date, suggesting healthy investor interest and recent momentum.

Negative Factors

Moderate Expense Ratio

The fund’s fee is higher than many low-cost index ETFs, which can slightly reduce long-term returns for buy-and-hold investors.

Concentration in Financials and Industrials

A large share of assets is in financial and industrial companies, which could hurt performance if these sectors face a downturn.

Mixed Performance Among Top Holdings

While some leading positions have delivered strong gains, others have been weak or slightly negative this year, creating uneven contribution to returns.

TOUS vs. SPDR S&P 500 ETF (SPY)

AUM1.31B

RegionDeveloped Markets

Expense Ratio0.50%

Beta0.73

IssuerT. Rowe Price

Inception DateJun 14, 2023

Dividend Yield1.75%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume219,493

30 Day Avg. Volume244,073

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

40.19

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering175

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

TOUS Summary

The T. Rowe Price International Equity ETF (TOUS) is an actively managed fund that invests in stocks from many countries outside the U.S., aiming to capture the total international market rather than tracking a specific index. It holds companies from Japan, the UK, Europe, and more, across sectors like financials, industrials, and technology. Well-known holdings include ASML Holding and Unilever. Someone might invest in TOUS to diversify beyond U.S. stocks and tap into growth in both developed and emerging markets. A key risk is that international stocks can be volatile and are affected by currency swings and global economic conditions.

How much will it cost me?The T. Rowe Price International Equity ETF (TOUS) has an expense ratio of 0.5%, which means you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, meaning professional managers are selecting investments rather than tracking a passive index.

What would affect this ETF?The T. Rowe Price International Equity ETF (TOUS) could benefit from growth in developed markets outside the U.S., particularly in sectors like financials, technology, and health care, which make up a significant portion of its holdings. However, potential risks include economic slowdowns in key regions, regulatory changes affecting top holdings like ASML or AstraZeneca, and currency fluctuations that could impact returns for U.S.-based investors. Global interest rate changes and geopolitical tensions may also influence the ETF's performance.

TOUS Top 10 Holdings

TOUS leans heavily into developed markets outside the U.S., with Europe and Japan doing much of the heavy lifting. ASML and Renesas are the fund’s high-octane chip plays, both rising and giving the portfolio a clear technology undercurrent despite tech not being the largest sector on paper. Health care giants AstraZeneca and Roche are also climbing steadily, adding a defensive but productive backbone. Financials like UniCredit and Mitsubishi UFJ are contributing, while Siemens looks more mixed, occasionally losing steam and keeping overall industrial exposure from fully hitting its stride.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	3.43%	$45.34M	€450.89B	82.31%	76 Outperform
AZN	AstraZeneca	2.67%	$35.34M	$297.58B	20.89%	80 Outperform
RR	Rolls-Royce Holdings	1.79%	$23.72M	£108.04B	71.54%	71 Outperform
UCG	UniCredit SpA	1.64%	$21.73M	€98.12B	34.11%	75 Outperform
ROG	Roche Holding AG	1.50%	$19.82M	CHF254.35B	25.81%	73 Outperform
6723	Renesas Electronics	1.43%	$18.87M	¥4.62T	6.91%	64 Neutral
ULVR	Unilever	1.41%	$18.67M	£105.49B	―	72 Outperform
DTE	Deutsche Telekom	1.28%	$16.88M	€160.41B	-2.40%	67 Neutral
SIE	Siemens	1.24%	$16.43M	€171.28B	-1.14%	74 Outperform
8306	Mitsubishi UFJ Financial Group	1.18%	$15.58M	¥29.68T	37.46%	76 Outperform

TOUS Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

36.37

Negative

100DMA

34.96

Negative

200DMA

33.55

Positive

Market Momentum

MACD

-0.50

Positive

RSI

29.39

Positive

STOCH

14.67

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TOUS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 36.67, equal to the 50-day MA of 36.37, and equal to the 200-day MA of 33.55, indicating a neutral trend. The MACD of -0.50 indicates Positive momentum. The RSI at 29.39 is Positive, neither overbought nor oversold. The STOCH value of 14.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TOUS.

TOUS Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
TOUS	―	―	$1.31B	0.50%	65 Neutral
DIHP	―	―	$5.53B	0.27%	68 Neutral
DFIS	―	―	$5.34B	0.39%	58 Neutral
DISV	―	―	$4.50B	0.42%	57 Neutral
CGIE	―	―	$1.91B	0.54%	64 Neutral
AVIV	―	―	$1.16B	0.25%	68 Neutral

Performance Comparison

TOUS

T. Rowe Price International Equity ETF

34.33

5.02

17.13%

DIHP

Dimensional International High Profitability ETF

―

DFIS

Dimensional International Small Cap ETF

―

DISV

Dimensional International Small Cap Value ETF

―

CGIE

Capital Group International Equity ETF

―

AVIV

Avantis International Large Cap Value ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents